Frequently Asked Questions

Get answers to common questions about Tirzepatide Follow-up (Virtual).

During the virtual follow-up, your provider reviews weight trends, side effects, vitals reported, medication adherence, and any lab results. They’ll adjust dosing when needed, provide lifestyle guidance, and answer questions to keep therapy safe and effective.

Frequency varies by individual and phase of treatment; typically follow-ups occur every two to four weeks during dose titration, then every one to three months for maintenance, or as needed for side effects or concerns.

Yes. Providers can authorize refills or modify dosing based on your response and safety parameters. If labs or in-person evaluation are required, they will advise next steps and coordinate necessary orders or appointments.

Some patients require baseline or periodic labs to monitor metabolic markers and medication safety. Your provider will order tests when indicated and arrange local lab draws or coordinate in-person visits if needed.

Have recent weight measurements, medication list, any side effect notes, glucose readings if applicable, and questions ready. Ensure a private space and reliable internet or phone connection for the virtual visit.

For most routine monitoring and symptom review, virtual visits are safe and effective. Providers will recommend in-person evaluations or testing when necessary to ensure proper monitoring and address any clinical concerns.